These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 16242951)
1. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Fujii M; Chambers DJ Eur J Cardiothorac Surg; 2005 Dec; 28(6):821-31. PubMed ID: 16242951 [TBL] [Abstract][Full Text] [Related]
2. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide. Fujii M; Avkiran M; Chambers DJ Ann Thorac Surg; 2004 Apr; 77(4):1398-407. PubMed ID: 15063274 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170 [TBL] [Abstract][Full Text] [Related]
4. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect? Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415 [TBL] [Abstract][Full Text] [Related]
5. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Penna C; Rastaldo R; Mancardi D; Raimondo S; Cappello S; Gattullo D; Losano G; Pagliaro P Basic Res Cardiol; 2006 Mar; 101(2):180-9. PubMed ID: 16450075 [TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. Rajesh KG; Sasaguri S; Suzuki R; Xing Y; Maeda H Int J Cardiol; 2004 Jul; 96(1):41-9. PubMed ID: 15203260 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels. Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348 [TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia. Zhu B; Min S; Long C; Ye T Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart. Hearse DJ; Ferrari R; Sutherland FJ J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023 [TBL] [Abstract][Full Text] [Related]
10. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. Yang XM; Proctor JB; Cui L; Krieg T; Downey JM; Cohen MV J Am Coll Cardiol; 2004 Sep; 44(5):1103-10. PubMed ID: 15337225 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406 [TBL] [Abstract][Full Text] [Related]
12. [-Myocardial protection by preconditioning. Experimental and clinical significance-]. Strasser R; Vogt A; Schaper W Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986 [TBL] [Abstract][Full Text] [Related]
13. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806 [TBL] [Abstract][Full Text] [Related]
14. Effect of G(alphaq/11) protein and ATP-sensitive potassium channels on prostaglandin E(1) preconditioning in rat hearts. Ma SG; Fu RF; Feng GQ; Wang ZJ; Ma XQ; Weng SA Acta Pharmacol Sin; 2004 May; 25(5):587-92. PubMed ID: 15132823 [TBL] [Abstract][Full Text] [Related]
15. Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart. Joyeux-Faure M; Ramond A; Béguin PC; Belaïdi E; Godin-Ribuot D; Ribuot C Fundam Clin Pharmacol; 2006 Feb; 20(1):51-6. PubMed ID: 16448394 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotection from ischemia-reperfusion injury due to Ras-GTPase inhibition is attenuated by glibenclamide in the globally ischemic heart. Al-Rashdan I; Canatan H; Al-Maghrebi M; Yousif MH; Khan SA; Benter IF Cell Biochem Funct; 2007; 25(4):455-61. PubMed ID: 16850529 [TBL] [Abstract][Full Text] [Related]
17. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats. Tawfik MK; Abo-Elmatty DM; Ahmed AA Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. Laclau MN; Boudina S; Thambo JB; Tariosse L; Gouverneur G; Bonoron-Adèle S; Saks VA; Garlid KD; Dos Santos P J Mol Cell Cardiol; 2001 May; 33(5):947-56. PubMed ID: 11343417 [TBL] [Abstract][Full Text] [Related]
19. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806 [TBL] [Abstract][Full Text] [Related]
20. Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts. Shinmura K; Tamaki K; Bolli R J Mol Cell Cardiol; 2005 Aug; 39(2):285-96. PubMed ID: 15878170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]